Product Details for: Reblozyl

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
For Injection
Subcutaneous
25MG/VIAL
Single-Dose Vial
351(a)
Reblozyl
Rx
002
For Injection
Subcutaneous
75MG/VIAL
Single-Dose Vial
351(a)
Reblozyl
Rx
Proper Name
luspatercept-aamt
BLA Number
761136
Applicant
Celgene Corporation, a Bristol-Myers Squibb Company
Original Approval Date
November 8, 2019
Date of First Licensure
RETURN TO SEARCH RESULTS